Desarrollo de nuevas estrategias de inmunoterapia
INFORMACIÓN DE CONTACTO
Grupo de Investigación
LASARTE SAGASTIBELZA, JUAN JOSE
Correo Electrónico
jjlasarte@unav.es
Arrizabalaga, L, Di Trani, CA, Risson, A, Belsúe, V, Gomar, C, Ardaiz, N, Berrondo, P, Aranda, F, Bella, A
"Peritoneal carcinomatosis in mouse models".
Methods Cell Biol.. 185: 67 - 78. 2024. [doi:10.1016/bs.mcb.2024.02.005]
Silva-Pilipich N, Beloki U, Apaolaza P, Igea A, Salaberry L, Prats-Mari L, Rovira E, Ondiviela M, Gorraiz M, Lasarte JJ, Vanrell L, Smerdou C
"Targeting PD-1(+) T cells with small-format immunocytokines enhances IL-12 antitumor activity.".
Mol Ther. 33(1): 297 - 316. 2025. [doi:10.1016/j.ymthe.2024.11.027]
Serrano, A, Casares, N, Trocóniz, IF, Lozano, T, Lasarte, JJ, Zalba, S, Garrido, MJ
"Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice.".
Acta Pharmacol Sin. 46(1): 171 - 183. 2025. [doi:10.1038/s41401-024-01338-0]
Serrano, A, Zalba, S, Lasarte, JJ, Troconiz, IF, Riva, N, Garrido, MJ
"Quantitative Approach to Explore Regulatory T Cell Activity in Immuno-Oncology.".
Pharmaceutics. 16(11): 1461. 2024. [doi:10.3390/pharmaceutics16111461]
Palacios-Berraquero, ML, Rodriguez-Marquez, P, Calleja-Cervantes, ME, Berastegui, N, Zabaleta, A, Burgos, L, Alignani, D, San Martin-Uriz, P, Vilas-Zornoza, A, Rodriguez-Diaz, S, Inoges, S, de Cerio, ALD, Tamariz, E, Rifon, J, Alfonso-Pierola, A, Lasarte, JJ, Paiva, B, Hernaez, M, Rodriguez-Otero, P, San-Miguel, J, Ezponda, T, Roberto, J, Prosper, F
"Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in multiple myeloma.".
Blood Adv.. 8(21): 5479 - 5492. 2024. [doi:10.1182/bloodadvances.2023012522]
|